跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SSP+ - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SSP+
Authorized
STANDARD
SSP+
maco pharma
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
22bbfd5dfe47e49b
Company
maco pharma
Type
Standard
Approval Details
Approval Id
22bbfd5dfe47e49b
Drug Approval Canada Name
SSP+
Product Name
SSP+
Status
Marketed
Status Date
2022-12-18
Original Market Date
2022-12-18
Din
02492075
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Ethical
Ahfs
96:00.00
Atc Original
V07AC BLOOD TRANSFUSION, AUXILIARY PRODUCTS
Atc Name
v 07 ac
Aig Number
0761850001
Company Name
maco pharma
Company Address
Rue Lorthiois, Mouvaux, Nord-Pas-De-Calais, France, 59420
Active Ingredients
DISODIUM PHOSPHATE
3.05 G / L
POTASSIUM CHLORIDE
0.37 G / L
MAGNESIUM CHLORIDE
0.3 G / L
SODIUM CHLORIDE
4.05 G / L
SODIUM ACETATE
4.42 G / L
SODIUM CITRATE
3.18 G / L
SODIUM PHOSPHATE MONOBASIC
1.05 G / L
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
22bbfd5dfe47e49b
Type
Standard
Back to Health Canada Approvals